Add like
Add dislike
Add to saved papers

Salvage peroral endoscopic myotomy is a promising treatment for achalasia following a myotomy failure.

BACKGROUND AND AIMS: Reintervention modalities following myotomy failure in achalasia patients have yet to be established. The efficacy and safety of salvage peroral endoscopic myotomy (POEM) for treatment of achalasia following a myotomy failure were evaluated in the study.

METHOD: Between August 2011 to August 2021, at the Endoscopy Center of Zhongshan Hospital, 219 achalasia patients who had previously undergone a myotomy underwent a salvage POEM and were thus retrospectively enrolled in this study. After propensity score matching (PSM), operation-related parameters were compared between the salvage POEM group and the naïve POEM group. Subgroup analysis was performed between patients with previous heller myotomy (HM) and patients with previous POEM.

RESULT: With similar baseline characteristics between both groups after PSM, the salvage POEM group presented with shorter tunnel length (11.8±2.2 vs. 12.8±0.9, p<0.0001) and myotomy length (9.8±2.0 vs. 10.4±1.0, p<0.0001) than the naïve POEM group. There were no significant differences in procedure-related adverse events (AEs) between patients of salvage POEM and naïve POEM. The primary outcome of treatment success occurred in 175 of 193 patients (90.7%) in salvage POEM group vs. 362 of 374 patients (96.8%) in naïve POEM group (p = 0.0046). Significantly higher rate of clinical failures were observed at the 2-year and 5-year follow-ups in the previous HM subgroup than the previous POEM subgroup (p = 0.0433, p = 0.0230, respectively).

CONCLUSION: Salvage POEM following a previous myotomy failure, especially after POEM failure, is a promising treatment option as it has a durable clinical relief rate.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app